United Therapeutics
UTHR
#1026
Rank
$22.12 B
Marketcap
$489.31
Share price
1.08%
Change (1 day)
30.70%
Change (1 year)

Revenue for United Therapeutics (UTHR)

Revenue in 2025 (TTM): $3.12 Billion USD

According to United Therapeutics's latest financial reports the company's current revenue (TTM ) is $3.12 Billion USD. In 2024 the company made a revenue of $2.87 Billion USD an increase over the revenue in the year 2023 that were of $2.32 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for United Therapeutics from 1999 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) $3.12 B8.72%
2024 $2.87 B23.63%
2023 $2.32 B20.2%
2022 $1.93 B14.88%
2021 $1.68 B13.63%
2020 $1.48 B2.38%
2019 $1.44 B-11%
2018 $1.62 B-5.65%
2017 $1.72 B7.91%
2016 $1.59 B9.08%
2015 $1.46 B13.76%
2014 $1.28 B15.36%
2013 $1.11 B21.93%
2012 $0.91 B23.26%
2011 $0.74 B24.14%
2010 $0.59 B61.86%
2009 $0.36 B31.39%
2008 $0.28 B33.45%
2007 $0.21 B32.14%
2006 $0.15 B37.71%
2005 $0.11 B57.51%
2004 $73.59 M37.96%
2003 $53.34 M77.09%
2002 $30.12 M425.5%
2001 $5.73 M179.7%
2000 $2.04 M309.85%
1999 $0.5 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Eli Lilly
LLY
$59.41 B 1,799.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$29.08 B 829.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$16.77 B 436.25%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Pfizer
PFE
$62.78 B 1,906.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
$11.02 B 252.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
$87.21 M-97.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
$42.35 B 1,253.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cardinal Health
CAH
$234.31 B 7,389.77%๐Ÿ‡บ๐Ÿ‡ธ USA